Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2025-12-26 @ 1:27 AM
NCT ID:
NCT03370133
Group ID:
EG003
Title:
Any Bimekizumab 320 mg Q4W (AMS)
Description:
This arm consisted of all participants who received bimekizumab 320 mg Q4W at any time in the study (up to Week 52). It also includes the participants that switched from placebo to bimekizumab 320 mg Q4W after the 16-week Initial Treatment Period. Participants formed the SS.
Deaths Number Affected:
2
Deaths Number At Risk:
None
Serious Number Affected:
24
Serious Number At Risk:
395
Other Number Affected:
192
Other Number At Risk:
395
Study:
NCT03370133
Results Section:
NCT03370133
Adverse Events Module:
NCT03370133